Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;59(4):771-776.
doi: 10.20471/acc.2020.59.04.27.

THE ENIGMA OF LEWY BODY DEMENTIA: A CASE REPORT

Affiliations
Case Reports

THE ENIGMA OF LEWY BODY DEMENTIA: A CASE REPORT

Ivona Orlović et al. Acta Clin Croat. 2020 Dec.

Abstract

Lewy body dementia is a progressive neurodegenerative disease and is considered to be the second most common cause of dementia in the elderly. Because of the complexity of clinical presentation, it is often misdiagnosed and mistaken for other dementias, which may result in administering inappropriate therapy, and thus worsening of the patient condition. We reviewed a case of a 71-year-old patient whose clinical presentation gradually occurred with complex visual hallucinations, atypical extrapyramidal motor symptoms, fluctuating cognitive impairments with delirious episodes, and oscillating syncope. Depressive mood, impaired daily functioning and sensitivity to antipsychotics were also noted. Extensive diagnostic workup was performed with neuropsychological testing and use of single-photon emission computerized tomography. Considering the clinical presentation and diagnostic procedures performed, the diagnosis of Lewy body dementia was set and pharmacotherapy was revised. We discuss the importance of taking overall clinical presentation and diagnostic treatment in consideration and applying appropriate therapy to slow down the progression of the disease and exacerbation of the patient's psychological functions.

Keywords: Cholinesterase inhibitors; Cognitive dysfunction; Dementia; Hallucinations; Lewy body disease; Parkinsonian disorders.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
SPECT scan with 123-I ioflupane showing elevated basal brain activity, along with severe functional impairment of the striatal dopamine system.

References

    1. Moore DP, Puri BK. Neurodegenerative and movement disorders. In: Moore DP, Puri BK. Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience, 3rd edn. London: Hodder Arnold 2012;398-41.
    1. Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673–83. 10.1017/S0033291713000494 - DOI - PubMed
    1. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth Consensus Report of the DLB Consortium. Neurology. 2017;89(1):88–100. 10.1212/WNL.0000000000004058 - DOI - PMC - PubMed
    1. Mrak RE, Griffin WS. Dementia with Lewy bodies: definition, diagnosis, and pathogenic relationship to Alzheimer’s disease. Neuropsychiatr Dis Treat. 2007;3(5):619–25. - PMC - PubMed
    1. Byrne EJ, Lennox G, Lowe J, et al. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry. 1989;52:709–17. 10.1136/jnnp.52.6.709 - DOI - PMC - PubMed

Publication types